Skip to main content

AVP Research Foundation | Clinical Care, Research & Ayurvedic Education

Book an Appointment
Donate
Book Now
Menu

Clinical Trial Details

A 36 week study to investigate efficacy and sustainability of individualized Ayurveda treatment sub-optimally controlled Type 2 diabetes patients on top of pre-existing Oral drug therapy



Study Phase

Phase 3

Enrollment

Study Sites

Study Duration



About the Trial

This study evaluates the effectiveness and long-term sustainability of individualized Ayurveda treatment as an adjunct to oral hypoglycemic drugs in patients with Type 2 Diabetes Mellitus over a period of 36 weeks.


Detailed Description

A randomized, open-label, parallel-group clinical trial conducted to assess glycemic control, quality of life, safety, and long-term benefits of individualized Ayurveda management in Type 2 Diabetes Mellitus patients receiving standard oral anti-diabetic medication.


Study Timeline & Recruitment

Recuitment Start

Recuitment End

Study Start

Primary Completion

Study Completion


Sample Size

Enrollment Type

Target Sample Size

Current Enrollment

Study Arms

Sample Size Justification


Study Sites

Site Name City State Country Principal Investigator
No study sites available.

Ethics & Regulatory

Ethics Approval
Ethics Committee Name
Approval Number
Approval Date
Regulatory Approval
Regulatory Authority
Regulatory Approval Number
Regulatory Approval Date

Eligibility Criteria

Inclusion Criteria

Gender
Minimum Age
Maximum Age
Healthy Volunteers
Exclusion Criteria

No contact available.
Primary Objective

Secondary Objectives

Exploratory Objectives

Primary Outcomes

No Primary Outcomes Available.

Secondary Outcomes

No Secondary Outcomes Available.

Sponsors & Support

Primary Sponsor Name
Sponsor Type
Country
Documents

No Documents Available.

Trial Status

Yet to begin
CTRI Number
Registered on 01-01-1970
Last Updated 01-01-1970
Recruitment Start Date 01-01-1970
Estimated Completion 01-01-1970
CTRI Website

Key information

Study Type Interventional
Study Design
Allocation Randomized
Masking Open Label
Control Type Active Control
Primary Purpose Treatment

Need More Information?

If you are interested in participating or have any questions about the this trial, please contact us.

Contact Trial Team

Feedback